The past few years have seen a massive surge in prescriptions for glucagon-like peptide 1 receptor agonists (GLP-1 RAs), a type of medication initially approved for the treatment of type 2 diabetes and more recently for weight loss
By slowing gastric emptying, they create a feeling of fullness and reduce hunger sensations, helping patients consume fewer calories and experience gradual, sustainable weight loss
Using backup contraception for four weeks after starting and after each dose escalation is recommended
Our team monitors your progress and adjusts your dosage as needed
Novo Nordisk has sued Eli Lilly in New Jersey federal court, alleging that national ads for Zepbound and Mounjaro rely on outdated clinical trial comparisons that omit the highest available doses of Wegovy and Ozempicnewer options that Novo says materially undermine Lillys claims of broad superiority
Stress is defined as a non-specific event leading to injuries in various organs